Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-IL33 Antibody (R1A51)

Catalog #:   RMB74001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, WB
Accession: Q8BVZ5
Overview

Catalog No.

RMB74001

Species reactivity

Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

DVS27, IL 1F11, IL 33, IL1F11, IL33, Interleukin 1 family member 11, Interleukin 33, Interleukin 33 precursor, Interleukin33, NFEHEV, NFHEV, IL 33

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q8BVZ5

Applications

IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4 ℃ short term (1-2 weeks). Store at -20 ℃ 12 months. Store at -80 ℃ long term.

Clone ID

R1A51

Data Image
  • Western blot
    Western blot analysis of IL-33 expression in mouse lung cell lysate.
References

IL-33 Has a Protective Effect Against Perinatal Listeriosis by Regulating Mitophagy of CD8+ T Lymphocytes., PMID:40512525

Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation., PMID:40500403

Targeting IL-33 to Suppress Ferroptosis and Alleviate Inflammation in Asthma Exacerbations., PMID:40499633

Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4-Dinitrochlorobenzene-Induced Mouse Model of Atopic Dermatitis., PMID:40484710

Mechanistic insights into ozone-induced asthma exacerbation: role of oxidative stress and IL-33., PMID:40446373

Enhancing the Affinity of a Novel Selective scFv for Soluble ST2 through Computational Design., PMID:40417773

Interleukin 33 Promotes Liver Sinusoidal Endothelial Cell Dysfunction and Hepatic Fibrosis in Diabetic Mice., PMID:40403761

Vaccination against helminth IL-33 modulators permits immune-mediated parasite ejection., PMID:40378045

IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion., PMID:40371594

Microneedles Coated with Cow's Milk Proteins: Immunogenicity, Stability, and Safety Assessment., PMID:40366634

Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis., PMID:40347402

Anti-ST2 antibody reduces airway hyperresponsiveness mediated by monocyte-derived macrophages during influenza A infection., PMID:40319941

Sensitization Potential of the Major Soybean Allergen Gly m 4 and Its Cross-Reactivity with the Birch Pollen Allergen Bet v 1., PMID:40243572

Molecular and Immunometabolic Landscape of Erythrophagocytosis-induced Ferroptosis., PMID:40231500

IgE-Mediated Activation of Mast Cells and Basophils in Health and Disease., PMID:40165512

A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4., PMID:40154559

Development of a point-of-care test for the simultaneous detection of respiratory syncytial virus and IL-33 as a disease biomarker in children., PMID:40148664

IL-33 facilitates endoplasmic reticulum stress and pyroptosis in LPS-stimulated ARDS model in vitro., PMID:40118005

Maintenance of graft tissue-resident Foxp3+ cells is necessary for lung transplant tolerance in mice., PMID:40100295

IL-33-Induced TREM2+ Macrophages Promote Pathological New Bone Formation Through CREG1-IGF2R Axis in Ankylosing Spondylitis., PMID:40091508

Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis., PMID:40082721

Protease-activated receptor 2 and interleukin-13 receptor α1 activation is linked to eosinophilic chronic rhinosinusitis., PMID:40074076

Maternal supplementation with α-tocopherol inhibits the development of offspring food allergy, H1R signaling and ultimately anaphylaxis early in life., PMID:40073242

Depletion of eosinophils during sensitization but not challenge phase in mice blocks the development of food allergy early in life., PMID:40073088

Comment on "IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma"., PMID:40067408

Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis., PMID:40060399

Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression., PMID:40058506

IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity., PMID:40048372

TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders., PMID:40010414

Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives., PMID:40004611

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers., PMID:39981242

IL-33 signaling is dispensable for the IL-10-induced enhancement of mast cell responses during food allergy., PMID:39935481

IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential., PMID:39925809

Emerging biological treatments for asthma., PMID:39873193

Targeting alarmins in asthma: From bench to clinic., PMID:39855362

IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma., PMID:39835991

Baicalein attenuates ovalbumin-induced allergic rhinitis through the activation of nuclear receptor subfamily 4 group a member 1., PMID:39808359

Fibroblast growth factor 21 alleviated atopic march by inhibiting the differentiation of type 2 helper T cells., PMID:39798471

IL-33, a neutrophil extracellular trap-related gene involved in the progression of diabetic kidney disease., PMID:39797951

The evaluation of the serum levels of vitamin D and interleukin-33 in children with atopic dermatitis and its association with diseases severity., PMID:39775933

Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itching., PMID:39721714

IL-33/ST2 axis mediates diesel exhaust particles-induced mast cell activation., PMID:39707175

IL-5-producing Group 2 innate lymphoid cells promote T cell-independent IgA production in cooperation with eosinophils., PMID:39656643

Adventitial Injection of Hyaluronic Acid/Sodium Alginate Hydrogel Loaded With IL-33 Antibody Decreases Neointimal Hyperplasia., PMID:39667249

NOD1 signaling regulates early tissue inflammation during helminth infection., PMID:39662675

Εosinophilic Chronic Obstructive Pulmonary Disease. What Do We Know So Far?, PMID:39661227

Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells., PMID:39632879

IL33-induced neutrophil extracellular traps (NETs) mediate a positive feedback loop for synovial inflammation and NET amplification in rheumatoid arthritis., PMID:39617790

Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts., PMID:39606712

IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity., PMID:39605647

Datasheet

Document Download

Anti-IL33 Antibody (R1A51).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-IL33 Antibody (R1A51) [RMB74001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only